{"id":"W3088751416","doi":"10.1016/j.annonc.2020.08.411","title":"309P Real-world effectiveness of alpelisib (ALP) + fulvestrant (FUL) compared with standard treatment among patients (Pts) with hormone-receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2–) PIK3CA-mutated (Mut) advanced breast cancer (ABC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Internal medicine; Oncology; Cohort; Clinical endpoint; Fulvestrant; Progression-free survival; Metastatic breast cancer; Clinical trial; Cancer; Chemotherapy; Breast cancer; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001095786,0.0004006304,0.0008611607,0.0002299338,0.0001600216,0.0006179081,0.000287523,0.0006298123,0.006820026],"category_scores_gemma":[0.002663109,0.0001500494,0.002059749,0.000299191,0.0003200037,0.0007364387,0.0002909784,0.001194336,0.0005044636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006409358,"about_ca_system_score_gemma":0.0003892495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001478824,"about_ca_topic_score_gemma":0.001860018,"domain_scores_codex":[0.9994061,0.0003488971,0.00003758101,0.00009341411,0.00004022122,0.00007380938],"domain_scores_gemma":[0.9985111,0.0007993509,0.0003133989,0.0000707876,0.00006308482,0.0002422556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9155587,0.003044573,0.01835844,0.0003691035,0.002066693,0.00009583384,0.00003907176,0.002736063,0.001600718,0.0001422165,0.002284326,0.05370419],"study_design_scores_gemma":[0.230249,0.4453444,0.2877991,0.0002496137,0.009570568,0.0005537859,0.0003300392,0.01479846,0.003204657,0.001200993,0.006556053,0.0001432954],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928198,0.002303649,0.0001927153,0.0004583315,0.0001888012,0.0001083512,0.00221497,0.00003433705,0.001679133],"genre_scores_gemma":[0.9975259,0.0003483015,0.000163293,0.0001728155,0.00008320979,0.00006654104,0.001063096,0.000004357283,0.0005723959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006820026,"threshold_uncertainty_score":0.02281523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0303983865183438,"score_gpt":0.3392094778581987,"score_spread":0.3088110913398548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}